NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in NextCure, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +4 vs. Q4 2023
- Shares held
- 16.1M
- +2.80M (+21.0%) vs. Q4 2023
- Total value
- $36.0M
- +$20.7M (+135.7%) vs. Q4 2023
- New holders
- 6
- 9 more added
- Sold out
- 2
- 12 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $5.96M | 0.35% | 00.0% | Unchanged |
| Logos Global Management LP | 1,925,000 | $4.29M | 0.45% | +1,925,000 | New |
| Affinity Asset Advisors, LLC | 1,359,037 | $3.03M | 0.49% | +1,359,037 | New |
| OrbiMed Advisors LLC | 1,141,200 | $2.54M | 0.05% | −1,569,813−57.9% | Reduced |
| Millennium Management LLC | 1,134,078 | $2.53M | 0.00% | −6,311−0.6% | Reduced |
| Vanguard Group Inc | 987,324 | $2.20M | 0.00% | +83,700+9.3% | Added |
| BlackRock Inc. | 761,334 | $1.70M | 0.00% | −128,768−14.5% | Reduced |
| Cable Car Capital LLC | 615,878 | $1.37M | 1.92% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 556,105 | $1.24M | 0.14% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 488,440 | $1.09M | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 426,717 | $951.6K | 0.00% | +426,717 | New |
| Morgan Stanley | 402,258 | $897.0K | 0.00% | +321,430+397.7% | Added |
| Renaissance Technologies LLC | 400,400 | $893.0K | 0.00% | +107,085+36.5% | Added |
| Schonfeld Strategic Advisors LLC | 393,240 | $876.9K | 0.01% | +393,240 | New |
| Federated Hermes, Inc. | 327,405 | $730.1K | 0.00% | −442−0.1% | Reduced |
| Acuitas Investments, LLC | 321,657 | $717.3K | 0.36% | −51,142−13.7% | Reduced |
| BML Capital Management, LLC | 306,465 | $683.4K | 0.46% | 00.0% | Unchanged |
| Cardiff Park Advisors, LLC | 262,000 | $584.3K | 0.06% | +262,000 | New |
| Citadel Advisors LLC | 245,476 | $547.4K | 0.00% | −130,374−34.7% | Reduced |
| Hudson Bay Capital Management LP | 203,800 | $454.5K | 0.00% | +203,800 | New |
| Geode Capital Management, LLC | 174,707 | $389.7K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 150,000 | $335.0K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 144,520 | $322.3K | 0.03% | −323,402−69.1% | Reduced |
| Sio Capital Management, LLC | 130,000 | $289.9K | 0.10% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 85,853 | $191.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 70,600 | $157.4K | 0.00% | −24,000−25.4% | Reduced |
| Barclays PLC | 67,548 | $150.6K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 58,259 | $129.9K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 57,700 | $128.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 57,092 | $127.3K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 43,014 | $95.9K | 0.03% | −17,400−28.8% | Reduced |
| Ieq Capital, LLC | 37,342 | $83.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,746 | $75.3K | 0.00% | +742+2.2% | Added |
| LPL Financial LLC | 27,000 | $60.2K | 0.00% | +11,968+79.6% | Added |
| XTX Topco Ltd | 19,680 | $43.9K | 0.01% | +2,452+14.2% | Added |
| HSBC Holdings PLC | 17,363 | $38.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,813 | $24.1K | 0.00% | +4,546+72.5% | Added |
| HarbourVest Partners LLC | 10,044 | $22.4K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,000 | $22.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,726 | $6.08K | 0.00% | +2,701+10,804.0% | Added |
| Tower Research Capital LLC (TRC) | 2,274 | $5.07K | 0.00% | −5,817−71.9% | Reduced |
| Wells Fargo & Company | 2,157 | $4.81K | 0.00% | +2,002+1,291.6% | Added |
| JPMorgan Chase & Co | 803 | $1.79K | 0.00% | −702−46.6% | Reduced |
| Rhumbline Advisers | 703 | $1.57K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 385 | $859 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 48 | $107 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 17 | $0 | 0.00% | −248−93.6% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,550−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −19,588−100.0% | Sold out |